FR2372806B1 - - Google Patents
Info
- Publication number
- FR2372806B1 FR2372806B1 FR7713518A FR7713518A FR2372806B1 FR 2372806 B1 FR2372806 B1 FR 2372806B1 FR 7713518 A FR7713518 A FR 7713518A FR 7713518 A FR7713518 A FR 7713518A FR 2372806 B1 FR2372806 B1 FR 2372806B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762619638 DE2619638A1 (de) | 1976-05-04 | 1976-05-04 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2372806A1 FR2372806A1 (fr) | 1978-06-30 |
FR2372806B1 true FR2372806B1 (fr) | 1980-02-29 |
Family
ID=5977020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7713518A Granted FR2372806A1 (fr) | 1976-05-04 | 1977-05-04 | Pyrrolidones, leur procede de preparation et leur application therapeutique |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS52133975A (fr) |
BE (1) | BE854268A (fr) |
DE (1) | DE2619638A1 (fr) |
DK (1) | DK194377A (fr) |
ES (1) | ES458264A1 (fr) |
FR (1) | FR2372806A1 (fr) |
GB (1) | GB1583163A (fr) |
IT (1) | IT1086223B (fr) |
NL (1) | NL7704739A (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4320136A (en) | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
US4321201A (en) | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
US5021568A (en) * | 1988-04-22 | 1991-06-04 | Shipov Alexandr G | Lactam-1-acetic acid carbalkoxymethyl esters and method for preparing same |
CZ20022048A3 (cs) | 1999-12-22 | 2004-03-17 | Pfizer Products Inc. | Selektivní agonisty receptoru EP4 při léčení osteoporosy |
AU2001290250A1 (en) * | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
CZ20031257A3 (cs) * | 2000-11-27 | 2004-04-14 | Pfizer Products Inc. | Selektivní agonisty receptoru EP4 při léčení osteoporosy |
JP4211605B2 (ja) | 2001-07-16 | 2009-01-21 | 小野薬品工業株式会社 | プロスタノイドアゴニストとしての2ピロリドン誘導体 |
DE60208568T2 (de) * | 2001-07-16 | 2006-10-05 | F. Hoffmann-La Roche Ag | Prostaglandinanaloga als ep4-rezeptoragonisten |
PL367740A1 (en) | 2001-07-23 | 2005-03-07 | Ono Pharmaceutical Co, Ltd. | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
US7402605B2 (en) | 2002-03-05 | 2008-07-22 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
JP4754820B2 (ja) * | 2002-06-10 | 2011-08-24 | メルク セローノ ソシエテ アノニム | プロスタグランジン作動薬としてのγラクタムおよびその使用 |
PL378342A1 (pl) | 2003-01-10 | 2006-03-20 | F. Hoffmann-La Roche Ag | Pochodne 2-piperydonu jako agoniści prostaglandyn |
EP1586564B1 (fr) * | 2003-01-21 | 2012-11-28 | Ono Pharmaceutical Co., Ltd. | Derives de 8-azaprostalangine et utilisations de ces derives en tant que medicaments |
US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
WO2006043655A1 (fr) | 2004-10-22 | 2006-04-27 | Ono Pharmaceutical Co., Ltd. | Préparation thérapeutique pour inhalation |
CN104640542B (zh) | 2012-07-19 | 2017-09-22 | 开曼化学股份有限公司 | 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物 |
JP6368351B2 (ja) | 2013-03-15 | 2018-08-01 | ケイマン ケミカル カンパニー, インコーポレーテッド | ジフルオロラクタムアナログを合成する方法 |
WO2014144610A1 (fr) * | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Composés lactames en tant qu'agonistes sélectifs du récepteur ep4 pour l'utilisation dans le traitement de maladies et d'états à médiation par ep4 |
WO2014144584A2 (fr) * | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Composés de lactame en tant qu'antagonistes sélectifs du récepteur ep4 pour une utilisation dans le traitement de maladies et d'états médiés par l'ep4 |
US10729810B2 (en) | 2013-07-19 | 2020-08-04 | Cayman Chemical Company, Inc | Methods, systems, and compositions for promoting bone growth |
-
1976
- 1976-05-04 DE DE19762619638 patent/DE2619638A1/de active Pending
-
1977
- 1977-04-28 ES ES458264A patent/ES458264A1/es not_active Expired
- 1977-04-29 NL NL7704739A patent/NL7704739A/xx not_active Application Discontinuation
- 1977-05-02 IT IT23096/77A patent/IT1086223B/it active
- 1977-05-03 DK DK194377A patent/DK194377A/da unknown
- 1977-05-03 GB GB18427/77A patent/GB1583163A/en not_active Expired
- 1977-05-04 BE BE177278A patent/BE854268A/fr unknown
- 1977-05-04 JP JP5194577A patent/JPS52133975A/ja active Pending
- 1977-05-04 FR FR7713518A patent/FR2372806A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
IT1086223B (it) | 1985-05-28 |
ES458264A1 (es) | 1978-07-16 |
DK194377A (da) | 1977-11-05 |
JPS52133975A (en) | 1977-11-09 |
DE2619638A1 (de) | 1977-11-17 |
NL7704739A (nl) | 1977-11-08 |
BE854268A (fr) | 1977-11-04 |
FR2372806A1 (fr) | 1978-06-30 |
GB1583163A (en) | 1981-01-21 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |